Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TNXP Tonix Pharmaceuticals Holding Corporation

0,2404

0,1074 (80,75%)

20 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Tonix Pharmaceuticals Charts.

News Tonix Pharmaceuticals Holding Corporation

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
Montag 18 November 2024 (1 Tag vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Montag 18 November 2024 (2 Tage vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Mittwoch 13 November 2024 (6 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 13 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
Mittwoch 13 November 2024 (7 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Dienstag 12 November 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 8 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Montag 4 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Weitere Tonix Pharmaceuticals Holding Corporation News-Artikel

Deutsche Lufthansa

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen